downsides of glp 1 GLP-1 receptor agonists Why GLP-1 Drugs Alone Aren't

Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications

Ex9 had no effect on glucose tolerance in linagliptin-treated GcgRANull or in GcgRAVilCre mice

Patient safety cannot be compromised in the rush for growth

Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care

Lifestyle modification and nutrition-based approaches are regarded as the cornerstone strategies for treating pediatric obesity